LGND
Ligand Pharmaceuticals Inc.
stockNASDAQ
At CloseOct 30, 2026 4:03:30 PM EDT
324.00USD+2.102%(+6.67)344,311
Pre-marketOct 30, 2026 10:29:56 AM EDT
319.05USD+0.542%(+1.72)
Loading…
Loading…
6.44B
Healthcare
Biotechnology
CEO
John Higgins
HQ
San Diego, CA, USA
Previous Close
$317.33
Beta
0.78
52-Week High
$326.63 2026-07-08
52-Week Low
$175.89 2026-01-13
SMA 50
$296.39
SMA 200
$252.66
Avg. Vol 10D
244,347
Avg. Vol 30D
257,898
Avg. Vol 90D
291,459
Relative Vol
1.34
19.94M
19.52M
97.89%
2,501,915
12.84%
10.53
48%/52%
77.14%
56.70%
0.4100%
150,000
43
1,090
5,586
Apr 3, 2007 · $2.500
Nov 19, 2010 · 1-for-5.9999 (reverse)
253.8M
51.5M
90.6M
Oct 30, 2026
Ligand (LGND) Q3 2026 Earnings Call Transcript · 
The Motley Fool
Oct 29, 2026
Ligand Reports Third Quarter 2026 Financial Results · 
GlobeNewswire Inc.
LGND Profile
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
LGND Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 303.53 | 2026-10-23 | +6.42% | 0.080 |
| 1M | 302.74 | 2026-10-01 | +6.69% | 1.014 |
| 3M | 287.54 | 2026-07-31 | +12.33% | 0.845 |
| 6M | 227.44 | 2026-05-01 | +42.02% | 0.623 |
| 1Y | 191.31 | 2025-10-31 | +68.84% | 0.778 |
| 2Y | 105.70 | 2024-10-31 | +205.58% | — |
| 5Y | 151.49 | 2021-11-01 | +113.22% | 1.100 |
LGND Stock Summary
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $323.00, and today's volume is 344,311. LGND is up 1.787% today. The 30 day average volume is 257,898. LGND market cap is $6.44B with 19.94M shares outstanding.